# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
BioCardia shares are trading lower by 12% during Friday's session. The company announced the pricing of an upsized public o...
BioCardia shares are trading higher by 95% during Thursday's session. The FDA cleared the company to market its Morph DNA S...